论文部分内容阅读
目的:分析氨溴索注射液治疗支气管肺炎的临床疗效。方法:随机将我院收治的40例患者分为对照组和试验组,临床对对照组患者主要采用注地塞米松静脉滴注治疗,对试验组患者主要采用氨溴索注射液治疗,并观察两组患者治疗效果。结果:试验组患者中治愈9例,好转10例,无效1例,有效率95.0%;对照组患者中,治愈6例,好转6例,无效8例,有效率60.0%;且试验组患者在喘憋消失时间以及心率恢复正常时间等方面,均优于对照组;两组患者之间差异有统计学意义(P<0.05)。结论:在临床支气管肺炎治疗中,对患者采用氨溴索注射液辅助治疗方法,可以有效改善患者的临床症状,较常规治疗有极大的优势,值得在实际中推广。
Objective: To analyze the clinical efficacy of ambroxol injection in the treatment of bronchial pneumonia. Methods: Forty cases of patients admitted to our hospital were randomly divided into control group and experimental group. The patients in control group were treated with intravenous injection of dexamethasone intravenously. The patients in experimental group were treated with ambroxol injection and observed Two groups of patients treatment effect. Results: In the experimental group, 9 cases were cured, 10 cases were improved, 1 case was ineffective, and the effective rate was 95.0%. In the control group, 6 cases were cured, 6 cases improved, 8 cases were ineffective, and the effective rate was 60.0% Wheezing disappeared time and heart rate returned to normal time, etc., were better than the control group; the difference between the two groups was statistically significant (P <0.05). Conclusion: In the clinical treatment of bronchopneumonia, ambroxol injection in patients with adjuvant therapy can effectively improve the clinical symptoms of patients, compared with conventional treatment has great advantages, it is worth promoting in practice.